List of Feraheme drug patents

Feraheme is owned by Covis.

Feraheme contains Ferumoxytol.

Feraheme has a total of 1 drug patent out of which 0 drug patents have expired.

Feraheme was authorised for market use on 30 June, 2009.

Feraheme is available in solution;intravenous dosage forms.

The generics of Feraheme are possible to be released after 30 June, 2023.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US6599498 COVIS Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohdrate derivatives
Jun, 2023

(5 months from now)

Drugs and Companies using FERUMOXYTOL ingredient

Market Authorisation Date: 30 June, 2009

Treatment: NA

Dosage: SOLUTION;INTRAVENOUS

How can I launch a generic of FERAHEME before it's patent expiration?
More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in